Site Search
Use small fonts Use medium fonts Use large fonts Email link to page


Related expertise

Cassels Brock Represents the Underwriters in Khiron's $28.84 Million Financing

Published: 02/28/2019

Team: Nancy Choi, Stefan Politano, Christopher B. Norton, Tera Li Parizeau

On February 28, 2019, Khiron Life Sciences Corp. completed a bought deal short form prospectus offering of common shares, including the exercise in full of the over-allotment option. A total of 13,110,000 common shares were sold at a price of $2.20 per common share for aggregate gross proceeds of approximately $28.84 million. 

The offering was completed by a syndicate of underwriters co-led by Canaccord Genuity Corp. and BMO Nesbitt Burns Inc., and including Cormark Securities Inc.

Cassels Brock acted for the underwriters with a deal team that included Nancy Choi and Stefan Politano (Securities and Cannabis) and Chris Norton and Tera Li Parizeau (Tax).